EVRG:NASDAQEvergy, Inc. Analysis
Data as of 2026-05-25 - not real-time
$83.94
Latest Price
3/10Risk
Risk Level: Low
Executive Summary
Evergy (EVRG) posted a solid Q1 earnings beat, delivering $0.69 EPS versus the $0.61 consensus and a modest revenue uplift of 2.15%, reinforcing its defensive utility profile. The stock is trading at $83.94, comfortably above its 20‑day SMA of 82.38, 50‑day SMA of 81.97 and 200‑day SMA of 77.34, while the MACD line sits at 0.39 above its signal, indicating bullish momentum. RSI at 57.6 suggests the price is not yet overbought, and the market respects a technical support near 80.30 and resistance around 84.09.
However, the DCF‑derived fair value of roughly $27 implies a significant overvaluation, with the current price implying a 7.9% upside‑downside gap relative to intrinsic estimates. The dividend yield of 3.31% looks attractive, but a payout ratio of ~72% combined with negative free cash flow raises questions about sustainability. Low beta (0.08) and modest 30‑day volatility (~19.8%) keep market risk subdued, yet the heavy debt load (DE/Equity >150) and regulatory exposure typical for utilities add a layer of medium‑level risk.
However, the DCF‑derived fair value of roughly $27 implies a significant overvaluation, with the current price implying a 7.9% upside‑downside gap relative to intrinsic estimates. The dividend yield of 3.31% looks attractive, but a payout ratio of ~72% combined with negative free cash flow raises questions about sustainability. Low beta (0.08) and modest 30‑day volatility (~19.8%) keep market risk subdued, yet the heavy debt load (DE/Equity >150) and regulatory exposure typical for utilities add a layer of medium‑level risk.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bullish technical indicators (price above SMAs, MACD bullish)
- Recent earnings beat reinforcing short‑term momentum
- Proximity to resistance limiting upside in the near term
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Significant valuation gap versus DCF fair value
- Stable utility cash flows supporting dividend but debt burden high
- Regulatory environment providing earnings stability but limiting growth
Long Term
> 3 yearsCautious
Model confidence: 7/10
Key Factors
- Persistent overvaluation relative to intrinsic estimates
- Elevated debt-to-equity ratio and negative free cash flow
- Uncertain dividend sustainability amid capital‑intensive operations
Key Metrics & Analysis
Financial Health
Revenue Growth5.00%
Profit Margin14.63%
P/E Ratio22.3
ROE8.87%
ROA2.90%
Debt/Equity155.56
P/B Ratio1.9
Op. Cash Flow$2.0B
Free Cash Flow$-1101750016
Industry P/E22.0
Technical Analysis
TrendBullish
RSI57.6
Support$80.30
Resistance$84.09
MA 20$82.38
MA 50$81.97
MA 200$77.34
MACDBullish
VolumeStable
Fear & Greed Index91.75
Valuation
Fair Value$27.08
Target Price$90.63
Upside/Downside7.96%
GradeOvervalued
TypeValue
Dividend Yield3.31%
Risk Assessment
Beta0.08
Volatility19.77%
Sector RiskLow
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.